| • | | A Private Placement Warrants Purchase Agreement, dated September 14, 2021 (the “Cantor Private Placement Warrants Purchase Agreement”; together with the Sponsor Private Placement Warrants Purchase Agreement, the “Private Placement Warrants Purchase Agreements”), by and between the Company and Cantor, a copy of which is attached as Exhibit 10.5 hereto and incorporated herein by reference. |
| • | | Indemnity Agreements, dated September 14, 2021, by and between the Company and each of the directors and officers of the Company, a form of which is attached as Exhibit 10.6 hereto and incorporated by reference. |
| • | | An Administrative Support Agreement, dated September 14, 2021, by and between the Company and the Sponsor, a copy of which is attached as Exhibit 10.7 hereto and incorporated herein by reference. |
Item 3.02. Unregistered Sales of Equity Securities.
Simultaneously with the closing of the IPO, pursuant to the Private Placement Warrants Purchase Agreements, the Company completed the private sale of an aggregate of 9,500,000 warrants (the “Private Placement Warrants”) to the Sponsor and Cantor (6,500,000 Private Placement Warrants to the Sponsor and 3,000,000 Private Placement Warrants to Cantor) at a purchase price of $1.00 per Private Placement Warrant, generating gross proceeds to the Company of $9,500,000. The Private Placement Warrants are identical to the Warrants included in the Units sold as part of the Units in the IPO, except as otherwise disclosed in the Registration Statement. No underwriting discounts or commissions were paid with respect to such sale. The issuance of the Private Placement Warrants was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended.
Item 5.02. | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
On September 14, 2021 and in connection with the IPO, Brenda Frank, Alex Zoghlin and Ivan Brockman (the “Directors”) were appointed to the board of directors of the Company (the “Board”). The Directors are independent directors.
Effective September 14, 2021, Ivan Brockman, Brenda Frank and Alex Zoghlin were appointed to the Board’s audit committee, with Ms. Frank serving as chair. Effective September 14, 2021, Mr. Zoghlin and Ms. Frank were appointed to the Board’s compensation committee, with Mr. Zoghlin serving as chair.
Following the appointment of the Directors, the Board is comprised of the following three classes: the term of office of the first class of directors, Class I, consists of Richard Burke and will expire at the Company’s first annual meeting of stockholders; the term of office of the second class of directors, Class II, consists of Kenneth L. Campbell and will expire at the Company’s second annual meeting of stockholders; and the term of office of the third class of directors, Class III, consists of Ivan Brockman, Brenda Frank and Alex Zoghlin and will expire at the Company’s third annual meeting of stockholders.
On September 14, 2021, in connection with their appointments to the Board, each Director entered into the Letter Agreement as well as the Indemnity Agreement with the Company.
Other than the foregoing, none of the Directors are party to any arrangement or understanding with any person pursuant to which they were appointed as directors, nor are they party to any transactions required to be disclosed under Item 404(a) of Regulation S-K involving the Company.
The foregoing descriptions of the Letter Agreement and the form of Indemnity Agreement do not purport to be complete and are qualified in their entireties by reference to the Letter Agreement and form of Indemnity Agreement, copies of which are attached as Exhibit 10.1 hereto and Exhibit 10.5, respectively, and are incorporated herein by reference.